000			01459 a2200397 4500
005			20250514003546.0
264		0	_c20010802
008			200108s 0 0 eng d
022			_a0003-9942
024	7		_a10.1001/archneur.58.7.1056 _2doi
040			_aNLM _beng _cNLM
100	1		_aMarcus, D A
245	0	0	_aEstablishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans). _h[electronic resource]
260			_bArchives of neurology _cJul 2001
300			_a1056-8 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAnalgesics, Non-Narcotic _xtherapeutic use
650	0	4	_aCarbazoles _xtherapeutic use
650	0	4	_aClinical Trials as Topic
650	0	4	_aHumans
650	0	4	_aIndoles _xtherapeutic use
650	0	4	_aMigraine Disorders _xdrug therapy
650	0	4	_aOxazolidinones _xtherapeutic use
650	0	4	_aPain Measurement _xmethods
650	0	4	_aPatient Satisfaction
650	0	4	_aPiperidines _xtherapeutic use
650	0	4	_aPyrrolidines _xtherapeutic use
650	0	4	_aSerotonin Receptor Agonists _xtherapeutic use
650	0	4	_aSumatriptan _xtherapeutic use
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aTriazoles _xtherapeutic use
650	0	4	_aTryptamines
773	0		_tArchives of neurology _gvol. 58 _gno. 7 _gp. 1056-8
856	4	0	_uhttps://doi.org/10.1001/archneur.58.7.1056 _zAvailable from publisher's website
999			_c11376873 _d11376873